CAS No. |
465-18-9 |
中文名称 |
(R)-2-[(5R,10S,13R,14R,16R,17R)-16-羟基-4,4,10,13,14-五甲基-3-氧代-2,3,4,5,6,10,12,13,14,15,16,17-十二氢-1H-环戊并[a]菲-17-基]-6-甲基-5-亚甲基庚酸 |
英文名称 |
(R)-2-((5R,10S,13R,14R,16R,17R)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-2,3,4,5,6,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methyl-5-methyleneheptanoic acid |
别名 |
16α-Hydroxy-24-methylene-3-oxo-5α-lanosta-7,9(11)-dien-21-oic acid;16α-Hydroxy-24-methylene-3-oxo-5α-lanosta-7,9(11)-diene-21-oic acid;3-Oxo-16α-hydroxy-24-methylene-5α-lanosta-7,9(11)-diene-21-oic acid;Polyporenic acid C;16alpha-Hydroxy-24-methylene-3-oxo-5alpha-lanosta-7,9(11)-diene-30-oic acid;Lanosta-7,9(11)-dien-21-oic acid, 16-hydroxy-24-methylene-3-oxo-, (16α)-;(2S)-2-[(10S,13R,14R,16R,17R)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid;cell,Apoptosis,inhibit,Inhibitor,lung,cancer,NSCLC,Polyporenic acid C |
标准英文名 |
(R)-2-((5R,10S,13R,14R,16R,17R)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-2,3,4,5,6,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methyl-5-methyleneheptanoic acid |
MDL No. |
- |
分子式 |
C31H46O4 |
分子量 |
482.70
|
精确分子量 |
482.34
|
SMILES |
C=C(CC[C@@H](C(=O)O)[C@H]1[C@H](O)C[C@@]2(C)C3=CC[C@H]4C(C)(C)C(=O)CC[C@]4(C)C3=CC[C@]12C)C(C)C |
标准SMILES |
CC1(C)[C@@H]2CC=C3C(=CC[C@]4(C)[C@@H]([C@@H](CCC(=C)C(C)C)C(O)=O)[C@H](O)C[C@]43C)[C@@]2(C)CCC1=O |
用途 |
Potential application in lung cancer research; induction of apoptosis via death receptor-mediated pathway; used in content determination, identification, and pharmacological experiments. |
InChIKey |
KPKYWYZPIVAHKU-WMNQUVFJSA-N |